HOMEPRODUCTSCOMPANYCONTACTFAQResearchDictionaryPharmaSign Up FREE or Login

Gastric cancer screening of a high-risk population in Japan using serum pepsinogen and barium digital radiography.

Abstract
With the aim of developing more efficient gastric cancer screening programs for use in Japan, we studied a new screening program that combines serum pepsinogen (PG) testing and barium digital radiography (DR). A total of 17 647 middle-aged male subjects underwent workplace screening over a 7-year period using a combination of PG testing and DR. This program's effectiveness, as well as other characteristics of the program, was analyzed. Forty-nine cases of gastric cancer were detected (comprising 88% early cancer cases). The detection rate was 0.28%, and the positive predictive value was 0.85%. The PG test detected 63.3% of cases, DR detected 69.4% of cases, and both tests were positive in 32.7% of cancer cases. The two methods were almost equally effective, and were considerably more effective than conventional screening using photofluorography. Each screening method detected a distinct gastric cancer subgroup; the PG test efficiently detected asymptomatic small early cancer with intestinal type histology, while DR was efficient at detecting cancers with depressed or ulcerated morphology and diffuse type histology. The cost for the detection of a single cancer was much less than that for conventional screening. In fact, it is possible to further reduce the cost of detecting a single cancer to a cost comparable to that of surgically resecting a single gastric cancer. Thus, it is probable that a highly efficient gastric cancer screening system can be implemented by combining the two screening methods. Such a screening program would be beneficial in a population at high risk for gastric cancer.
AuthorsHiroshi Ohata, Masashi Oka, Kimihiko Yanaoka, Yasuhito Shimizu, Chizu Mukoubayashi, Kouichi Mugitani, Masataka Iwane, Hideya Nakamura, Hideyuki Tamai, Kenji Arii, Hiroya Nakata, Noriko Yoshimura, Tetsuya Takeshita, Kazumasa Miki, Osamu Mohara, Masao Ichinose
JournalCancer science (Cancer Sci) Vol. 96 Issue 10 Pg. 713-20 (Oct 2005) ISSN: 1347-9032 [Print] England
PMID16232204 (Publication Type: Clinical Trial, Journal Article, Research Support, Non-U.S. Gov't)
Chemical References
  • Biomarkers, Tumor
  • Barium
  • Pepsinogen A
Topics
  • Barium
  • Biomarkers, Tumor (blood)
  • Diagnosis, Differential
  • Humans
  • Male
  • Mass Screening (methods)
  • Middle Aged
  • Pepsinogen A (blood)
  • Predictive Value of Tests
  • Radiographic Image Enhancement
  • Risk Factors
  • Sensitivity and Specificity
  • Stomach Neoplasms (diagnostic imaging, pathology)
  • Workplace

Join CureHunter, for free Research Interface BASIC access!

Take advantage of free CureHunter research engine access to explore the best drug and treatment options for any disease. Find out why thousands of doctors, pharma researchers and patient activists around the world use CureHunter every day.
Realize the full power of the drug-disease research graph!


Choose Username:
Email:
Password:
Verify Password:
Enter Code Shown: